ARTICLE | Company News
Alfresa Pharma, Sanofi deal
April 16, 2012 7:00 AM UTC
The companies partnered to develop and commercialize epilepsy treatment vigabatrin in Japan to treat children with epilepsia nutans. The irreversible inhibitor of GABA transaminase (GABA T) is market...